Alembic Pharmaceuticals to raise funds up to Rs 300 crore

10 Sep 2018 Evaluate

Alembic Pharmaceuticals has received an approval for issue of Unsecured Listed Non-Convertible Debentures (NCDs) of up to Rs 300 crore on Private Placement Basis. The Board of Directors of the company at its meeting held on September 10, 2018, approved the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×